Internalization and Cycling of the T Cell Antigen Receptor - Role of Protein Kinase C

Component: Cell Model; Description: 2B4 murine T cell hybridoma — antigen-specific (pigeon cytochrome c / Ia-restricted); expresses ~20,000-30,000 TCRs/cell

Component: Anti-Receptor Antibody; Description: A2B4-2 — mouse monoclonal IgG2a; recognizes clone-specific determinant on TCR α chain of 2B4 cells

Component: Fab Fragments; Description: Monovalent A2B4-2 fragments prepared by pepsin digestion (16-18 h) + reduction/alkylation

Component: Crosslinking Antibody; Description: Rabbit anti-mouse IgG (affinity purified) — used to crosslink surface-bound A2B4-2

Component: Phorbol Ester; Description: PMA (phorbol 12-myristate 13-acetate) — PKC activator; dose range 0.1-100 ng/mL

Component: Radiolabeling; Description: ¹²⁵I labeling of A2B4-2 and Fab fragments (Enzymobeads, lactoperoxidase/glucose oxidase); specific activity 4000-8000 cpm/ng

Component: Internalization Assay; Description: Acid resistance (0.5 M NaCl, 0.5 M acetic acid, pH 2.2) — acid strips surface-bound antibody; acid-resistant = internalized

Component: Phosphorylation Analysis; Description: ³²P orthophosphate labeling (0.4 mCi/mL, 1 h); immunoprecipitation with A2B4-2; SDS-PAGE; autoradiography; densitometry

Parameter: Binding/Internalization Protocol; Details: Cells saturated with ¹²⁵I-A2B4-2 at 4°C (30 min); unbound antibody removed; cells warmed to 37°C; acid-resistant vs. total cell-associated counts measured at time points

Parameter: PMA Treatment; Details: 100 ng/mL PMA (unless indicated); added during prebinding (4°C) or during warming (37°C)

Parameter: PKC Depletion; Details: 24-28 h treatment with 1 μg/mL PMA at 37°C; >98% PKC loss confirmed by inability of PMA to phosphorylate TCR γ chain

Parameter: Surface Receptor Measurement; Details: Saturation binding with ¹²⁵I-A2B4-2 at 4°C after PMA treatment at 37°C (30 min); nonspecific binding determined with 200-fold excess unlabeled antibody

Parameter: Steady-State Uptake; Details: Cells treated with/without PMA at 37°C for 30 min; ¹²⁵I-A2B4-2 added; total and acid-resistant counts measured over time

Parameter: Phosphorylation Dose Response; Details: ³²P-labeled cells treated with PMA (0-100 ng/mL) for 30 min; immunoprecipitation; SDS-PAGE; densitometry of γ and ε chain phosphorylation

Parameter: Replicates; Details: Triplicate determinations; means ± S.D. shown

Parameter: Controls; Details: Non-specific binding (200-fold excess unlabeled antibody); 4°C incubations (no internalization); PKC-depleted cells

Analysis Category: Receptor Internalization; Methods: Acid-resistance assay (pH 2.2, high salt); 5 s exposure; centrifugation through FCS; gamma counting

Analysis Category: Surface Receptor Number; Methods: Saturation binding at 4°C (30 min); 20 nM ¹²⁵I-A2B4-2; 200-fold excess for non-specific

Analysis Category: Fab Fragment Preparation; Methods: Pepsin digestion (16-18 h, 37°C); Protein A chromatography; reduction with 50 mM β-mercaptoethanol; alkylation with 25 mM iodoacetamide

Analysis Category: Crosslinking; Methods: Rabbit anti-mouse IgG (10 μg/mL) added to A2B4-2-bound cells prior to warming

Analysis Category: Protein Kinase C Depletion; Methods: 24-28 h treatment with 1 μg/mL PMA; confirmed by loss of PMA-induced TCR phosphorylation

Analysis Category: Phosphorylation; Methods: ³²P orthophosphate (0.4 mCi/mL, 1 h, 37°C); immunoprecipitation with A2B4-2/Protein A-agarose; SDS-PAGE (13% polyacrylamide); autoradiography; densitometry

Analysis Category: Cell Viability; Methods: Trypan blue exclusion (not shown but standard)

Condition: ¹²⁵I-A2B4-2 (whole IgG); % Internalized (30 min at 37°C): 20-30%; Significance: No increase beyond 30%

Condition: ¹²⁵I-Fab fragments; % Internalized (30 min at 37°C): 20-30%; Significance: Identical to whole IgG

Condition: 4°C control; % Internalized (30 min at 37°C): 0%; Significance: No internalization

Condition: Crosslinking (anti-IgG + A2B4-2); % Internalized (30 min at 37°C): 100%; Significance: Rapid internalization

Parameter: Surface TCR loss (30 min, 100 ng/mL PMA); Result: 40-60% reduction (EC₅₀ ~2-3 ng/mL)

Parameter: PMA-induced internalization (prebound ¹²⁵I-A2B4-2); Result: ~60% of total cell-associated

Parameter: PMA effect on Fab fragments; Result: Identical to whole IgG

Parameter: PKC depletion effect on basal internalization; Result: No effect

Parameter: PKC depletion effect on PMA-induced internalization; Result: Complete loss

Parameter: Surface receptors (4°C); Control: 100%; PMA-Treated: 100% (no PMA effect at 4°C)

Parameter: Total uptake at 37°C (30 min); Control: ~130% of initial; PMA-Treated: ~200% of initial

Parameter: % total A2B4-2 on cell surface; Control: 75%; PMA-Treated: 38%

Parameter: % total A2B4-2 internalized; Control: 25%; PMA-Treated: 62%

Parameter: Acid-resistant fraction (30 min); Control: ~25%; PMA-Treated: ~65%

Parameter: Time to reach steady state; Control: ~10 min; PMA-Treated: ~20 min

Parameter: Total cycling receptor pool; Control: Unchanged by PMA; PMA-Treated: Unchanged by PMA

Condition: PMA (100 ng/mL); Rate Increase vs. Control: 2.5-3× increase

Chain: γ chain; EC₅₀ for PMA-induced Phosphorylation: Sharp response (between 1-5 ng/mL); Maximal Phosphorylation: >95% of γ chains

Chain: ε chain; EC₅₀ for PMA-induced Phosphorylation: 7.4 ng/mL (broader response); Maximal Phosphorylation: -

Chain: Dose overlap with surface loss; EC₅₀ for PMA-induced Phosphorylation: γ chain phosphorylation; Maximal Phosphorylation: Matches receptor redistribution curve

1. Correlative evidence for phosphorylation mechanism: The authors explicitly state that "whether it is the phosphorylation of the receptor that leads to altered internalization or another, undefined cellular target of protein kinase C is not known and cannot be addressed by studies such as those reported here."

2. Unsuccessful recycling experiments: "We were unable to do this because attempts to remove surface ligand with a number of proteases or by brief exposure to acid led to cell damage and inhibition of internalization." This prevented direct measurement of recycling rates.

3. Antibody may perturb receptor function: While the authors show that Fab and whole IgG give identical results, they acknowledge "Does this antibody perturb the receptor? We think our data suggest that it does not, at least over the time course examined."

4. Single cell type: All experiments were performed on one T cell hybridoma (2B4); generalizability to primary T cells or other T cell subsets was not tested.

5. No functional outcome measured: The study did not examine whether altered TCR cycling affects antigen-induced IL-2 production or T cell activation, though the authors note "we have found no evidence for the inhibition of antigen-induced interleukin-2 production in these cells by PMA."

6. Historical methodology limitations: The acid-resistance assay, while widely used at the time, cannot distinguish between endosomal vs. lysosomal localization or provide detailed trafficking kinetics.

7. No intracellular localization studies: The study did not identify the intracellular compartments where internalized TCR resides (e.g., early endosomes, recycling endosomes).

8. Potential confounding from antibody-induced receptor crosslinking: While Fab fragments matched whole IgG results, the antibody itself might still stabilize receptor conformations that affect internalization differently from natural ligand.

9. No measurement of receptor degradation: The authors note "there was no evidence of antibody degradation (measured by trichloroacetic acid precipitation) over the time course of the experiments," but did not assess potential degradation of the TCR itself.

10. PMA effects on other signaling pathways: While PKC depletion experiments were performed, PMA may have other effects (e.g., on other kinases) that could contribute to altered trafficking.

Report prepared based on the published Journal of Biological Chemistry article. For full experimental details and complete references, please refer to the original publication.